New diabetes clinical trial: Glycation of apoA-I and Diabetic Atherogenesis

Published on: December 21, 2022 at 10:30PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: overnight fasting
Sponsor:   Ruijin Hospital
Active, not recruiting
https://ift.tt/cHve9yN